Heart failure in the elderly

Management of Acute Decompensated Heart Failure

Volumn , Issue , 2005, Pages 71-86

  Ghali, Jalal K ^a   Kitzman, Dalane W ^b  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70249129596     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780203421345-10     Document Type: Chapter

References (103)

1. National population projections. Washington, D.C.:Census Bureau, 2002. Available at: http://www. census.gov/population/www/projections/natproj.htm l. Accessed June 20, 2004.
2. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998; 98: 2282-2289.
3. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993; 22: 6A-13A.
4. Gottdiener JS, Arnold AM, Aurigemma GP, et al. Predictors of congestive heart failure in the elderly:the Cardiovascular Health Study. J Am Coll Cardiol 2000; 35: 1628-1637.
5. Cowie MR, Wood DA, Coats AJ, et al. Incidence and etiology of heart failure; a population-based study. Eur Heart J 1999; 20: 421-428.
6. Redfield MM, Jacobsen SJ, Burnett JC Jr., et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003; 289: 194-202.
7. Kitzman DW, Gardin JM, Gottdiener JS, et al. Importance of heart failure with preserved systolic function in patients ≥-65 years of age. CHS Research Group. Cardiovascular Heart Study. Am J Cardiol 2001; 87: 413-419.
8. Wei JY. Age and the cardiovascular system. N Engl J Med 1992; 327: 1735-1739.
9. Celermajer DS, Sorensen KE, Spiegelhalter DJ, et al. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 1994; 24: 471-476.
10. Virmani R, Avolio AP, Mergner WJ, et al. Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis:comparison between occidental and Chinese communities. Am J Pathol 1991; 139: 1119-1129.
11. Lakatta EG, Levy D. Arterial and cardiac aging:major shareholders in cardiovascular disease enterprises:Part II: the aging heart in health: links to heart disease. Circulation 2003; 107: 346-354.
12. Haider AW, Larson MG, Franklin SS, Levy D. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med 2003; 138: 10-16.
13. Franklin SS, Gustin W IVth, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997; 96: 308-315.
14. Olivetti G, Melissari M, Capasso JM, Anversa P. Cardiomyopathy of the aging human heart: myocyte loss and reactive cellular hypertrophy. Circ Res 1991; 68: 1560-1568.
15. Glenner GG. Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts). N Engl J Med 1980; 302: 1333-1343.
16. Lie JT, Hammond PI. Pathology of the senescent heart: anatomic observations on 237 autopsy studies of patients 90 to 105 years old. Mayo Clin Proc 1988; 63: 552-564.
17. Fowler NO. The Pericardium in Health and Disease (Mount Kisco, NY: Futura Publishing Company, 1985).
18. Gerstenblith G, Frederiksen J, Yin FC, et al. Echocardiographic assessment of a normal adult aging population. Circulation 1977; 56: 273-278.
19. Fleg JL, O’Connor FC, Gerstenblith G, et al. Impact of age on the cardiovascular response to dynamic upright exercise in healthy men and women. J Appl Physiol 1995; 78: 890-900.
20. Rodeheffer RJ, Gerstenblith G, Becker LC, et al. Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilatation and increased stroke volume compensate for a diminished heart rate. Circulation 1984; 69: 203-213.
21. Schulman SP, Fleg JL, Goldberg AP, et al. Continuum of cardiovascular performance across a broad range of fitness levels in healthy older men. Circulation 1996; 94: 359-367.
22. Schulman SP, Lakatta EG, Fleg JL, et al. Age-related decline in left ventricular filling at rest and exercise. Am J Physiol 1992; 263: H1932-H1938.
23. Swinne CJ, Shapiro EP, Lima SD, Fleg JL. Age-associated changes in left ventricular diastolic performance during isometric exercise in normal subjects. Am J Cardiol 1992; 69: 823-826.
24. Ziegler MG, Lake CR, Kopin IJ. Plasma noradrenaline increases with age. Nature 1976; 261: 333-335.
25. Esler MD, Turner AG, Kaye DM, et al. Aging effects on human sympathetic neuronal function. Am J Physiol 1995; 268: R278-R285.
26. Ng AV, Callister R, Johnson DG, Seals DR. Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. Hypertension 1993; 21:498-503.
27. White M, Roden R, Minobe W, et al. Age-related changes in beta-adrenergic neuroeffector systems in the human heart. Circulation 1994; 90: 1225-1238.
28. Tsunoda K, Abe K, Goto T, et al. Effect of age on the renin-angiotensin-aldosterone system in normal subjects:simultaneous measurement of active and inactive rennin, rennin substrate, and aldosterone in plasma. J Clin Endocrinol Metab 1986; 62: 384-389.
29. Stratton JR, Cerquerira MD, Schwartz RS, et al. Differences in cardiovascular responses to isoproterenol in relation to age and exercise training in healthy men. Circulation 1992; 86: 504-512.
30. O’Brien IAD, O’Hare P, Corrall RJM. Heart rate variability in healthy subjects: effect of age and the derivation of normal ranges for tests of autonomic function. Br Heart J 1985; 55: 348-354.
31. Pfeffer MA, Weinberg CR, Cook D, et al. Differential changes of autonomic nervous system function with age in man. Am J Med 1983; 75: 249-258.
32. Fleg JL, Kennedy HL. Cardiac arrhythmias in a healthy elderly population: detection by 24-hour ambulatory electrocardiography. Chest 1982; 81:302-307.
33. Fleg JL, Kennedy HL. Long-term prognosis significance of ambulatory electrocardiographic findings in apparently healthy subjects ≥-60 years of age. Am J Cardiol 1992; 70: 748-751.
34. Manolio TA, Furberg CD, Rautaharju PM, et al. Cardiac arrhythmias on 24-h ambulatory electrocardiography in older women and men: the Cardiovascular Health Study. J Am Coll Cardiol 1994; 23: 916-925.
35. Gerstenblith G, Lakatta EG, Weisfeldt ML. Age changes in myocardial function and exercise response. Prog Cardiovasc Dis 1976; 19: 1-21.
36. Dehn MM, Bruce RA. Longitudinal variations in maximal oxygen uptake with age and activity. J Appl Physiol 1972; 33: 805-807.
37. Lakatta EG. Cardiovascular regulatory mechanisms in advanced age. Physiol Rev 1993; 73: 413-467.
38. Shlipak MG. Pharmacotherapy for heart failure in patients with renal insufficiency. Ann Intern Med 2003; 138: 917-924.
39. Meyer BR, Bellucci A. Renal function in the elderly. Cardiol Clin 1986; 4: 227-234.
40. Montamat SC, Cusack BJ, Vestal RE. Management of drug therapy in the elderly. N Engl J Med 1989; 321: 303-309.
41. Cody RJ, Torre S, Clark M, Pondolfino K. Agerelated hemodynamic, renal, and hormonal differences among patients with congestive heart failure. Arch Intern Med 1989; 149: 1023-1028.
42. Lindeman RD. Changes in renal function with aging:implications for treatment. Drugs Aging 1992; 2:423-431.
43. Phillips PA, Rolls BJ, Ledingham JG, et al. Reduced thirst after water deprivation in healthy elderly men. N Engl J Med 1984; 311: 753-759.
44. Chen Y, Vaccarino V, Williams CS, Butler J, Berkman LF, Krumholz HM. Risk factors for heart failure in the elderly: a prospective community-based study. Am J Med 1999; 106: 605-612.
45. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KKL. The progression from hypertension to congestive heart failure. JAMA 1996; 275: 1557-1562.
46. Vasan RS, Sullivan LM, Roubenoff R, et al. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation 2003; 107:1486-1491.
47. Abramson J, Berger A, Krumholz HM, Vaccarino V. Depression and risk of heart failure among older persons with isolated systolic hypertension. Arch Intern Med 2001; 161: 1725-1730.
48. Williams SA, Kasl SV, Heiat A, et al. Depression and risk of heart failure among the elderly: a prospective community-based study. Psychosom Med 2002; 64:6-12.
49. Havranek EP, Masoudi FA, Westfall KA, Wolfe P. Spectrum of heart failure in older patients: results from the National Heart Failure Project. Am Heart J 2002; 143: 412-417.
50. Lien CT, Gillespie ND, Struthers AD, McMurdo ME. Heart failure in frail elderly patients: diagnostic difficulties, co-morbidities, polypharmacy and treatment dilemmas. Eur J Heart Fail 2002; 4: 91-98.
51. Turvey CL, Schultz K, Arndt S, Wallace RB, Herzog R. Prevalence and correlates of depressive symptoms in a community sample of people suffering from heart failure. J Am Geriatr Soc 2002; 50: 2003-2008.
52. Deedwania PC, Gottlieb S, Ghali JK, et al. Efficacy, safety and tolerability of beta-adrenergic blockade with Metoprolol CR/XL in elderly patients with heart failure. Eur Heart J 2004; 25: 1300-1309.
53. Opasich C, Tavazzi L, Lucci D, et al. Comparison of oneyear outcome in women versus men with chronic congestive heart failure. Am J Cardiol 2000; 86: 353-357.
54. Ghali JK, Cooper R, Ford E. Trends in hospitalization for heart failure in the United States, 1973-1986: evidence for increasing population prevalence. Arch Intern Med 1990; 150: 769-773.
55. Croft JB, Giles WH, Pollard RA, et al. National trends in the initial hospitalization for heart failure. J Am Geriatr Soc 1997; 45: 270-275.
56. Haldeman GA, Croft JB, Giles WH, Rashidee A. Hospitalization of patients with heart failure:National Hospital Discharge Survey, 1985-1995. Am Heart J 1999; 137: 352-360.
57. CDC National Center for Health Statistics. National Hospital Discharge Survey (NHDS) 2002. Available at: http://www.cdc.gov/nchs/about/major/hdasd/nhds. htm. Accessed June 29, 2004.
58. Masoudi FA, Havranek EP, Smith G, et al. Gender, age, and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 2003; 41:217-223.
59. Vasan RS, Larson MG, Benjamin EJ, et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction. J Am Coll Cardiol 1999; 33: 1948-1955.
60. Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 2004; 43: 317-327.
61. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part I. Diagnosis, prognosis, and measurements of diastolic function. Circulation 2002; 105: 1387-1393.
62. Wang TJ, Larson MG, Levy D, et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol 2002; 90: 254-258.
63. Redfield MM, Rodeheffer RJ, Jacobsen SJ, et al. Plasma brain natriuretic peptide concentration:impact of age and gender. J Am Coll Cardiol 2002; 40: 976-982.
64. Yusuf S, Pfeffer MA, Swedberg K, et al. the CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARMPreserved trial. Lancet 2003; 362: 777-781.
65. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure:the Framingham Study. N Engl J Med 1971; 285:1441-1446.
66. Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992; 20: 301-306.
67. Croft JB, Giles WH, Pollard RA, et al. Heart failure survival among older adults in the United States: a poor prognosis for an emerging epidemic in the Medicare population. Arch Intern Med 1999; 159:505-510.
68. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002; 347: 1397-1402.
69. MacIntyre K, Capewell S, Stewart S, et al. Evidence of improving prognosis in heart failure: trends in Case Fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation 2000; 102: 1126-1131.
70. Baker DW, Einstadter D, Thomas C, Cebul RD. Mortality trends for 23 505 Medicare patients hospitalized with heart failure in Northeast Ohio, 1991 to 1997. Am Heart J 2003; 146: 258-264.
71. Forman DE, Butler J, Wang Y, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 2004; 43: 61-67.
72. Krumholz HM, Chen Y, Vaccarino V, et al. Correlates and impact on outcomes of worsening renal function in patients ≥-65 years of age with heart failure. Am J Cardiol 2000; 85: 1110-1113.
73. Al-Ahmad A, Rand SM, Manjunath G, et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2001; 38: 955-962.
74. Kosiborod M, Smith GL, Radford MJ, Foody JM, Krunholz HM. The prognostic importance of anemia in patients with heart failure. Am J Med 2003; 114:112-119.
75. Krumholz HM, Butler J, Miller J, et al. Prognostic importance of emotional support for elderly patients hospitalized with heart failure. Circulation 1998; 97:958-964.
76. American Heart Association. Heart Disease and Stroke Statistics-2004 Update (American Heart Association: Dallas, TX, 2003).
77. Krumholz HM, Parent EM, Tu N, et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 1997; 157: 99-104.
78. Ghali JK. Decompensated heart failure revisited. Am J Med 2003; 114: 695-696.
79. Ghali JK, Kadakia S, Cooper R, Ferlinz J. Precipitating factors leading to decompensation of heart failure: traits among urban blacks. Arch Intern Med 1988; 148: 2013-2016.
80. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341: 709-717.
81. Cocchi A, Zuccala G, Menichelli P, et al. Congestive heart failure in the elderly: an intriguing clinical reality. Cardiology in the Elderly 1994; 2: 227-232.
82. Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study. Circulation 2003; 107:2920-2925.
83. Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med 2002; 162:1682-1688.
84. Lamy PP. Renal effects of nonsteroidal anti-inflammatory drugs: heightened risk to the elderly? J Am Geriatr Soc 1986; 34: 361-367.
85. Mamdani M, Juurlink DN, Lee DS, et al. Cyclooxygenase-2 inhibitors versus non-selective nonsteroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population- based cohort study. Lancet 2004; 363:1751-1756.
86. van Kraaij DJW, Jansen WMM, Bouwels LHR, Hoefnagels WHL. Furosemide withdrawal improves postprandial hypotension in elderly patients with heart failure and preserved left ventricular systolic function. Arch Intern Med 1999; 159: 1599-1605.
87. Howard PA, Dunn MI. Aggressive diuresis for severe heart failure in the elderly. Chest 2001; 119:807-810.
88. Rich MW, McSherry F, Williford WO, Yusuf S. Digitalis Investigation Group. Effect of age on mortality, hospitalization and response to digoxin in patients with heart failure: the DIG Study. J Am Coll Cardiol 2001; 38: 806-813.
89. Rathore SS, Curtis JP, Wang Y, Bristow MR, Krumholz HM. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 2003; 289: 871-878.
90. Flather MD, Yusuf S, Kober L, et al. Long-term ACEinhibitor therapy in patients with heart failure or leftventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 2000; 355: 1575-1581.
91. Gambassi G, Lapane KL, Sgadari A, et al. Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology. Arch Intern Med 2000; 160: 2550.
92. Johnson D, Jin Y, Quan H, Cujec B. Beta-blockers and angiotensin-converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada. J Am Coll Cardiol 2003; 42:1438-1445.
93. Sin DD, McAlister FA. The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11942 elderly patients with heart failure. Am J Med 2002; 113: 650-656.
94. Bristow MR, Saxon LA, Boehmer J, et al. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-2150.
95. Abraham WT, Fisher WG, Smith AL, et al. MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346:1845-1853.
96. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.
97. Piepoli MF, Flather M, Coats AJ. Overview of studies of exercise training in chronic heart failure: the need for a prospective randomized multicenter European trial. Eur Heart J 1998; 19: 830-841.
98. Smart N, Marwick TH. Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity. Am J Med 2004; 116: 693-706.
99. Levy WC, Cerqueira MD, Abrass IB, et al. Endurance exercise training augments diastolic filling at rest and during exercise in healthy young and older men. Circulation 1993; 88: 116-126.
100. Owen A, Croucher L. Effect of an exercise programme for elderly patients with heart failure. Eur J Heart Fail 2000; 2: 65-70.
101. McKelvie RS, Teo KK, Roberts R, et al. Effects of exercise training in patients with heart failure: the Exercise Rehabilitation Trial (EXERT). Am Heart J 2002; 144: 23-30.
102. Rich MW, Beckham V, Wittenberg C, et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995; 333: 1190-1195.
103. Stewart S, Horowitz JD. Home-based intervention in congestive heart failure: long-term implications on readmission and survival. Circulation 2002; 105:2861-2866.